Asia Pacific Next-generation Antibody Market to 2028 By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Next-generation Antibody Market – By Therapeutic Area

1.3.2 Asia Pacific Next-generation Antibody Market – By Technology

1.3.3 Asia Pacific Next-generation Antibody Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Next-generation Antibody Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Asia Pacific PEST Analysis

4.3 Experts Opinion

5. Next-generation Antibody Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Cancer

5.1.2 Growing Demand for Next-Generation Antibody Therapeutics

5.2 Market Restraints

5.2.1 Complications Associated with Manufacturing and Approvals

5.3 Market Opportunities

5.3.1 Proliferation of Biotechnology Industry in Developing Regions

5.4 Future Trends

5.4.1 Developments in Next-Generation Antibodies

5.5 Impact Analysis

6. Next-generation Antibody Market – Asia Pacific Analysis

6.1 Asia Pacific Next-generation Antibody Market Revenue Forecast and Analysis

7. Asia Pacific Next-generation Antibody Market Revenue and Forecasts To 2028– by Therapeutic Area

7.1 Overview

7.2 Asia Pacific Next-generation Antibody Market, By Therapeutic Area, 2021 & 2028 (%)

7.3 Oncology

7.3.1 Overview

7.3.2 Oncology: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Autoimmune or Inflammatory

7.4.1 Overview

7.4.2 Autoimmune or Inflammatory: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

8. Next-generation Antibody Market Revenue and Forecasts To 2028 – Technology

8.1 Overview

8.2 Asia Paciifc Next-generation Antibody Market Share by Segment - 2021 & 2028 (%)

8.3 Antibody-drug conjugates

8.3.1 Overview

8.3.2 Antibody-drug conjugates: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.4 Bispecific antibodies

8.4.1 Overview

8.4.2 Bispecific antibodies: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.5 Fc engineered antibodies

8.5.1 Overview

8.5.2 Fc engineered antibodies: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.6 Antibody fragments and antibody-like proteins

8.6.1 Overview

8.6.2 Antibody fragments and antibody-like proteins: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.7 Biosimilar antibody products

8.7.1 Overview

8.7.2 Biosimilar antibody products: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Next-generation Antibody Market Revenue and Forecasts to 2028 –Country Analysis

9.1 Asia Pacific Next-generation Antibody Market Revenue and Forecasts To 2028

9.1.1 Overview

9.1.2 Asia Pacific Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3 Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.4 Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology(US$ Million)

9.1.5 Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Country (%)

9.1.5.1 Japan: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.1.1 Overview

9.1.5.1.2 Japan: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.1.3 Japan: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.5.1.4 Japan: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.1.5.2 China: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.2.1 Overview

9.1.5.2.2 China: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.2.3 China: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.5.2.4 China: Next-generation Antibody Market Revenue and Forecasts to 2028, by Technology (US$ Million)

9.1.5.3 India Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.3.1 Overview

9.1.5.3.2 India: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.3.3 India: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.5.3.4 India: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.1.5.4 South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.4.1 Overview

9.1.5.4.2 South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.4.3 South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.5.4.4 South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.1.5.5 Australia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.5.1 Overview

9.1.5.5.2 Australia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.5.3 Australia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.5.5.4 Australia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Application (US$ Million)

9.1.5.6 Rest of Asia Pacific: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.6.1 Overview

9.1.5.6.2 Rest of Asia Pacific: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.6.3 Rest of Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.5.6.4 Rest of Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10. Impact Of COVID-19 Pandemic on Next-generation Antibody Market

10.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11. Next-generation Antibody Market–Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 F. HOFFMANN-LA ROCHE LTD.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Kyowa Kirin Co., Ltd.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Seagen Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Takeda Pharmaceutical Company Limited

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Amgen Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Pfizer Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Catalent Inc

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 AstraZeneca

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. New Cancer Cases Registered Worldwide, 2020

Table 2. Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million).

Table 3. Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 4. Japan: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 5. Japan: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 6. China: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 7. China: Next-generation Antibody Market Revenue and Forecasts to 2028, by Technology (US$ Million)

Table 8. India: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 9. India: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10. South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 11. South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 12. Australia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 13. Australia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 14. Rest of Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 15. Rest of Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 16. Organic Developments in the Next-generation Antibody Market

Table 17. Inorganic Developments in the Next-generation Antibody Market

Table 18. Glossary of Terms

LIST OF FIGURES

Figure 1. Next-generation Antibody Market Segmentation

Figure 2. Next-generation Antibody Market, By Country

Figure 3. Asia Pacific Next-generation Antibody Market Overview

Figure 4. Oncology Segment Held Largest Share of Therapeutic Area Segment in Next-generation Antibody Market

Figure 5. Asia Pacific Next-generation Antibody Market- Leading Country Markets (US$ Million)

Figure 6. Asia Pacific: PEST Analysis

Figure 7. Experts Opinion

Figure 8. Next-Generation Antibody Market Impact Analysis of Driver and Restraints

Figure 9. Asia Pacific Next-generation Antibody Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 10. Asia Pacific Next-generation Antibody Market, by Therapeutic Area, 2021 & 2028 (%)

Figure 11. Oncology: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Autoimmune or Inflammatory: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Asia Paciifc Next-generation Antibody Market Share by Segment - 2021 & 2028 (%)

Figure 14. Antibody-drug conjugates: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15. Bispecific antibodies: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16. Fc engineered antibodies: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17. Antibody fragments and antibody-like proteins: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18. Biosimilar antibody products: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19. Asia Pacific Next-generation Antibody Market Overview, by Country (2021)

Figure 20. Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Country (%)

Figure 22. Japan: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. China: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. India: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Australia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Rest of Asia Pacific: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Impact of COVID-19 Pandemic in Asia Pacific Country Markets